Procter & Gamble Health Ltd
PGHL
Company Profile
Business description
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.
Contact
Cardinal Gracias Road
Ground Floor And First Floor, P&G Plaza
Chakala, Andheri East
MumbaiMH400099
INDT: +91 22 68669000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2026
Employees
1,545
Stocks News & Analysis
stocks
Anglo American strikes deal to create a new copper giant
We are surprised that Teck agreed to the merger on these terms, and wouldn’t be surprised if there is a twist in the tale.
stocks
The ‘other’ AI chip behemoth that might just be getting started
The magnitude of growth at Broadcom continues to astound us.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,071.40 | 9.10 | -0.10% |
| CAC 40 | 7,802.30 | 40.98 | 0.53% |
| DAX 40 | 23,647.00 | 14.05 | 0.06% |
| Dow JONES (US) | 45,490.92 | 220.42 | -0.48% |
| FTSE 100 | 9,270.22 | 44.83 | 0.49% |
| HKSE | 26,106.01 | 94.25 | -0.36% |
| NASDAQ | 21,886.06 | 6.57 | 0.03% |
| Nikkei 225 | 44,372.50 | 534.83 | 1.22% |
| NZX 50 Index | 13,229.15 | 47.09 | -0.35% |
| S&P 500 | 6,532.04 | 19.43 | 0.30% |
| S&P/ASX 200 | 8,805.00 | 8.80 | -0.10% |
| SSE Composite Index | 3,875.31 | 63.09 | 1.65% |